# Globe Life account plan

> Globe Life is a Texas life and supplemental health insurer for middle-income US households: $5,994 million 2025 revenue, 3,695 employees.

## At a glance

Globe Life Inc. (NYSE: GL), headquartered in McKinney, Texas, sells individual life and supplemental health insurance to lower-middle and middle-income households in the United States, with branches and subsidiaries in Canada, New Zealand and Bermuda. It distributes through exclusive agencies (American Income Life, Liberty National, Family Heritage), a Direct to Consumer Division and independent agents (United American). In 2025 total revenue was $5,994 million, total premium rose 5% to $4.9 billion and net income was $1.16 billion ($14.07 per diluted share). At 31 December 2025 it had 3,695 employees and over 17,000 independently contracted agents. It is led by Co-Chairmen and CEOs J. Matthew Darden and Frank M. Svoboda.

## Business units

- **American Income Life Division** (about 39% of 2025 total premium; 53% of life premium ($1,791 million)): Exclusive agency selling life and supplemental health insurance to working families, marketing to labor union members and affinity groups, with most sales made through virtual presentations. It had 11,920 average producing agents in 2025 and is the largest contributor to underwriting margin, but its agent count fell to 11,331 in Q3 2026 (-7%) on lower new-agent retention.
- **Direct to Consumer Division** (about 22% of 2025 total premium): Sells adult and juvenile life insurance and some Medicare Supplement nationwide through direct mail, insert media and digital marketing, and generates leads for the exclusive agencies. Net sales fell 7% to $78 million in the first nine months of 2026 as AI in consumer search reduced paid search volume.
- **Liberty National Division** (about 12% of 2025 total premium): Exclusive agency selling life and cancer, critical illness and accident cover to middle-income households in-home and at worksites, with a plan to expand from Southeast small towns into larger cities. Average producing agents rose to 4,187 (+9%) in Q3 2026.
- **Family Heritage Division** (about 10% of 2025 total premium; health premium $468 million): Exclusive agency selling supplemental limited-benefit health insurance, mostly with return of premium, to families and small and medium-sized businesses. It is the largest health margin contributor, with a $175 million underwriting margin in 2025.
- **United American Division** (about 14% of 2025 total premium; health premium $667 million): Independent agents and brokers selling individual Medicare Supplement, retiree health and group worksite benefits, plus the group major medical start-up Evry Health. Health net sales rose 92% in 2025 on migration from Medicare Advantage, but its margin fell to 2% of premium in 2026 on higher claims and a $26 million Evry underwriting loss.
- **Other (independent agencies)** (about 4% of 2025 total premium): Life insurance sold through independent agencies: $201 million of life premium and 2% of life net sales in 2025.
- **Investment segment**: Manages the invested assets backing policy liabilities, mostly fixed maturities rated A-. Net investment income was $1,130 million in 2025 and excess investment income fell 16% to $138 million.

## Strategic priorities

- **Grow the exclusive agency forces**: Agent recruiting, middle-management development and retention are the main driver of sales; middle-management compensation was changed from Q2 2026 to lift recruiting and new-agent retention, with mid-single-digit agent and sales growth guided at American Income for H2 2026.
- **Adapt Direct to Consumer to AI search**: The division is moving into AI-embedded advertising and repositioning content to be "verified, visible, and easily interpreted by AI assistants", while expecting about one million leads for the agencies in 2026.
- **Use AI to cut administrative cost**: Management aims to bring administrative expenses from 7.3% of premium closer to 7% over the next few years, using AI across applications, service calls and claims, and training bots for agents.
- **Emphasise life, grow health selectively**: Life is 66% of premium and 79% of underwriting margin in the first nine months of 2026; health premium is guided to grow 14%-16% in 2026, with Evry addressed through pricing and underwriting discipline.
- **Return capital to shareholders**: A $2.5 billion repurchase authorization was approved in August 2026, 2026 buybacks are expected at $725-$775 million, and the quarterly dividend was raised 22% to $0.33.

## Latest results

For Q3 2026, net income was $361.1 million ($4.62 per diluted share) against $387.8 million ($4.73) a year earlier, and net operating income $378.8 million ($4.84 per share). Total premium revenue rose 7% to $1,311 million: life +2% to $865 million and health +16% to $447 million. Over the first nine months of 2026 net income rose 3% to $919 million and total net sales 10% to $727 million. Full-year 2026 net operating EPS guidance was cut to $15.35-$15.65 because of high-severity claims at Evry and a CMS claims processing delay, and first 2027 guidance is $16.10 to $17.10 per share, "an increase of 7.1% at the midpoint".

## Investments and deals

- **Globe Life Re Bermuda reinsurer**: A Bermuda Class C reinsurer licensed in late 2025 for a more efficient capital structure; Nebraska approved reciprocal jurisdiction, with some capital benefit expected in 2027 and the full benefit over three to five years.
- **Evry Health**: Acquired in 2024 for its technology-driven health insurance platform and broker relationships; sales are expected at about $50 million in 2026.
- **Agency technology**: Continued investment in a CRM tool and virtual recruiting, training and selling for the agency force, and new underwriting technology at Direct to Consumer.
- **Financing**: The term loan was raised from $250 million to $450 million and the credit facility extended to June 2031; long-term debt was $2.7 billion at 30 September 2026.

## Challenges and risks

- **Agent recruiting and retention**: American Income's average producing agent count fell 7% to 11,331 in Q3 2026 on lower retention of new agents, and life net sales there were flat.
- **AI-driven change in consumer search**: Growing use of AI in search reduced paid search volume and raised its cost, cutting Direct to Consumer life sales 15% in Q2 2026 and 12% in Q3 2026.
- **Health claims and Evry volatility**: United American posted a $6.4 million health underwriting loss in Q3 2026, mainly from about $16 million of Evry losses and about $7 million of excess Medicare Supplement claims from a CMS processing delay.
- **Litigation and agent classification**: A securities class action and shareholder derivative suits that followed April 2024 short-seller reports remain pending, and the EEOC found reasonable cause on independent contractor misclassification complaints.
- **Rate approvals and lapses**: Supplemental health depends on timely premium rate increases approved by regulators, and lapse rates are expected to stay above pre-pandemic levels in 2026.

## What leadership says

> "agent count growth is a precursor to sales growth" — Matt Darden, Co-Chief Executive Officer, Q2 2026 earnings call, 23 July 2026

> "DTC is in a transition period, due to a shift in the way consumers search online" — Matt Darden, Co-Chief Executive Officer, Q2 2026 earnings call, 23 July 2026

> "a vast majority of our growth in sales are coming through exclusive agency channels. We do not see or experience a lot of competition in those channels at the time of sale." — Matt Darden, Co-Chairman and Chief Executive Officer, Q1 2026 earnings call, 23 April 2026

> "that 7.3 percent of admin expenses as a percent of premium down closer to 7 percent a bit over the next few years" — Tom Kalmbach, EVP and CFO, On AI efficiency, Q1 2026 earnings call, 23 April 2026


## Where a supplier can help

- **Agent recruiting, onboarding and training**: The decline in American Income agents and the priority on agency growth make recruiting platforms, onboarding tools and training content relevant, alongside the training bots the company is building.
- **Visibility in AI search**: Direct to Consumer is repositioning content for AI assistants and buying AI-embedded advertising; agencies and tools that improve AI-search visibility and lead conversion tie directly to this challenge.
- **Claims and admin automation**: The aim to cut admin expenses toward 7% of premium through AI across applications, service calls and claims opens room for automation and AI vendors.
- **Health claims management**: High-severity claims at Evry and higher Medicare Supplement utilization make claims analytics, stop-loss and payment-integrity services relevant to United American.
- **Agency CRM and virtual selling**: Ongoing investment in the agency CRM tool and virtual sales presentations fits suppliers of CRM, video selling and sales analytics.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Globe Life Inc. Form 10-K 2025](https://www.sec.gov/Archives/edgar/data/320335/000032033526000090/gl-20251231.htm)

Annual report · 2026-02-25

- Globe Life Inc. is a McKinney, Texas insurance holding company selling basic protection individual life and supplemental health insurance to lower-middle and middle-income households in the US, through exclusive agencies (American Income Life, Liberty National, Family Heritage), a Direct to Consumer Division and independent agents (United American).
- FY2025: total revenue $5,994 million; total premium up 5% to $4.9 billion (life $3.4 billion, +3%; health $1.5 billion, +9%); net income $1.16 billion ($14.07 per diluted share, +18%); net operating income $1.20 billion ($14.52 per share, +17%).
- Returns: net income ROE 20.9%, net operating ROE excluding AOCI 16.0%; book value per share excluding AOCI up 11% to $96.16.
- Total net sales rose 13% to $948 million; health net sales rose 36% to $333 million, driven by Medicare Supplement demand as consumers shift away from Medicare Advantage (United American net sales +92%).
- American Income Life is the largest channel: 53% of 2025 life premium, 11,920 average producing agents, life underwriting margin of 49% of premium.
- Life is the predominant segment: 69% of total premium and 79% of total underwriting margin; life underwriting margin rose to 45% of premium (41% normalized), helped by improved mortality and a $130.9 million remeasurement gain.
- Capital return: 5.4 million shares repurchased for $685 million in 2025; $11.0 billion spent on buybacks since 1986; consolidated RBC ratio 316% against a 300%-320% target.
- New Bermuda reinsurance affiliate Globe Life Re Ltd. licensed in late 2025 for a more efficient capital structure.
- Main risks: recruiting and retaining agents, niche-market dependence (labor unions, affinity groups, direct response), independent contractor misclassification claims, short-seller allegations from April 2024 and the resulting securities class action and derivative suits, Medicare Supplement rate approvals, and IT/AI execution.

### [Globe Life Inc. Form 10-Q Q3 2026](https://www.sec.gov/Archives/edgar/data/320335/000032033526000231/gl-20260930.htm)

Interim report · 2026-11-04

- Nine months to 30 September 2026: net income $919 million (+3%), $11.64 per diluted share (+8%); net operating income $937 million, $11.86 per share (+7%).
- Net income ROE 19.7%; net operating ROE excluding AOCI 15.9%; book value per share excluding AOCI up 11% to $103.62.
- Total premium +6% to $3.9 billion: life +3% to $2.58 billion, health +15% to $1.30 billion; total net sales +10% to $727 million.
- American Income Division: 54% of life premium, life premium $1.4 billion (+5%), net sales $293 million, but average producing agent count down 6% on lower new-agent retention; middle-management compensation adjusted to lift recruiting and retention.
- Direct to Consumer net sales fell 7% to $78 million as growing consumer use of AI in search reduced paid search volume; the division is adapting content to be visible to AI assistants and expects about one million leads for the agencies this year.
- United American health net sales +77% on Medicare Supplement demand, but its margin fell to 2% of premium; Evry Health, its group major medical business, had a $26 million underwriting loss.
- Q3 assumption review gave a $120.5 million net remeasurement gain (2025: $134.3 million).
- Capital: 3.6 million shares bought back for $564 million; new $2.5 billion repurchase authorization (August 2026); quarterly dividend raised 22% to $0.33; long-term debt $2.7 billion.

### [Globe Life Inc. Third Quarter 2026 Results (earnings release)](https://www.sec.gov/Archives/edgar/data/320335/000032033526000224/q3fy2026earningsrelease.htm)

Interim report · 2026-10-21

- Q3 2026 (released 21 October 2026): net income $4.62 per diluted share (Q3 2025: $4.73); net operating income $4.84 per share (+1%), $378.8 million (-4%).
- Total premium revenue +7% to $1.31 billion: life +2% to $865 million, health +16% to $447 million.
- Life is 80% of insurance underwriting margin and 66% of premium; life underwriting margin fell 5% to $458 million (53% of premium) on smaller assumption-update gains.
- American Income Life: life premium +4% to $470 million, life underwriting margin +3% to $268 million; average producing agents 11,331 (-7% year on year).
- Liberty National life net sales +7% and agents +9% (4,187); Family Heritage health underwriting margin +12%.
- United American posted a $6.4 million health underwriting loss, mainly from about $16 million of losses at Evry and about $7 million of excess Medicare Supplement claims from a CMS processing delay.
- 2026 net operating EPS guidance cut to $15.35-$15.65; 2027 guidance $16.10-$17.10 (+7.1% at the midpoint).
- 2026 buyback expectation raised to $725-$775 million; 1.1 million shares bought in Q3 for $185 million.

### [Globe Life Q2 2026 earnings call transcript](https://investors.globelifeinsurance.com/getcontentasset/5a66f00e-83b8-409d-811d-2b0be939481f/50c2bc4c-a8ff-46ba-95c2-0e74752d147f/globe-life-inc-q2-2026-earnings-call-transcript-(final).pdf?language=en)

Executive talk · Frank Svoboda and Matt Darden, Co-Chief Executive Officers · 2026-07-23

- Q2 2026 call (23 July 2026) with Co-CEOs Frank Svoboda and Matt Darden and CFO Tom Kalmbach: net operating income $3.61 per share (+10%), double-digit per-share growth "in eight of the last nine quarters".
- 2026 guidance raised to net operating EPS of $15.55-$15.95; total premium growth 6.5%-7.0%, health premium growth 14%-16%.
- American Income Life: net life sales $95 million (-2%) on a 7% lower agent count (11,391), but agents up 3% since Q1 after incentive compensation changes; mid-single-digit agent and sales growth expected in H2.
- Direct to Consumer life sales fell 15% as AI-driven search cut paid search volume; Darden says the company will not "chase sales" below its margin targets and is shifting to AI-embedded advertising; more than 1 million leads for the agencies this year.
- United American health premium +29% on Medicare Supplement, but Evry Health (group health start-up) dragged margins; Evry sales expected at about $50 million in 2026, long-term loss ratio 83%-85%.
- AI: training bots for agents, enterprise-wide efficiency; admin expense ratio expected to decline over time.
- Capital: term loan raised to $450 million; 2026 buybacks $670-$700 million; Bermuda affiliate Globe Life Re got Nebraska reciprocal jurisdiction approval, Indiana next, dividends from it expected from 2027.

### [Globe Life Q1 2026 earnings call transcript](https://investors.globelifeinsurance.com/getcontentasset/239e4a36-e014-4922-a118-cfe5d25f3f1c/50c2bc4c-a8ff-46ba-95c2-0e74752d147f/globe-life-inc-q1-2026-earnings-release-call-transcript-apr-23,-2026-(final).pdf?language=en)

Executive talk · Frank Svoboda and Matt Darden, Co-Chairmen and Chief Executive Officers · 2026-04-23

- Q1 2026 call (23 April 2026), Co-CEOs Frank Svoboda and Matt Darden, CFO Tom Kalmbach: net operating income $274 million, $3.43 per share (+12%).
- 2026 guidance at the time: net operating EPS $15.40-$15.90; premium growth about 7%; health premium growth 14%-17%.
- Total life net sales +6% and health net sales +58%; United American health net sales $62 million, up about $34 million, on Medicare Advantage to Medicare Supplement migration.
- American Income: net life sales $101 million (+3%) on better productivity, but agents down 4% to 11,064 on weaker new-agent retention; middle-management compensation changed from Q2.
- AI: expected to bring admin expenses from 7.3% of premium "closer to 7 percent" over the next few years and to help agent onboarding; Darden sees agency-sold business as protected from new AI-era entrants, more competition in DTC.
- Resilient customer base: average premiums of $40-$60 a month; over 50% of the target demographic has no life insurance.
- Mortality improving (heart, non-lung cancer, non-medical deaths); third-quarter assumption gain then expected at $70-$110 million.
- 1.4 million shares bought for about $205 million; 2026 buybacks $560-$610 million; 22% dividend increase.

## Questions about Globe Life

### What does Globe Life do?

Globe Life sells individual life and supplemental health insurance, including Medicare Supplement, to lower-middle and middle-income US households through exclusive agencies, independent agents and direct-to-consumer channels.

### What is Globe Life's revenue?

Total revenue was $5,994 million in 2025, with total premium of $4.9 billion and net income of $1.16 billion. In Q3 2026 total premium revenue was $1,311 million.

### How many employees does Globe Life have?

Globe Life had 3,695 employees at 31 December 2025 and engaged over 17,000 independently contracted insurance agents.

### What is Globe Life's strategy?

It focuses on growing its exclusive agency forces, adapting direct marketing to AI-driven search, using AI to lower administrative costs and returning excess cash through buybacks and dividends.

### Who leads Globe Life?

J. Matthew Darden and Frank M. Svoboda are Co-Chairmen and Chief Executive Officers, and Thomas P. Kalmbach is Executive Vice President and CFO.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
